We are live on ! Find out more
SCLN

Sciclone Pharmaceuticals Inc
SCLN

Delisted

SCLN was delisted on the 13th of October, 2017.

Back to rankings

102 hedge funds and large institutions have $148M invested in Sciclone Pharmaceuticals Inc in 2013 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 41 increasing their positions, 34 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 34

1% more capital invested

Capital invested by funds: $147M → $148M (+$983K)

2% less funds holding

Funds holding: 104 → 102 (-2)

13% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 16

Holders
102
Holders Change
-2
Holders Change %
-1.92%
% of All Funds
3.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
41
Reduced
34
Closed
16
Calls
$304K
Puts
–
Net Calls
+$304K
Net Calls Change
+$403K

Top Buyers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$4.2M
2
AL
AJO LP
Pennsylvania
+$3.55M
3
Renaissance Technologies
Renaissance Technologies
New York
+$2.06M
4
BA
BlackRock Advisors
Delaware
+$2.02M
5
BFA
BlackRock Fund Advisors
California
+$1.49M

Top Sellers

Rank Fund Capital Flow
1
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$11.4M
2
AQR Capital Management
AQR Capital Management
Connecticut
-$2.29M
3
TC
TFS Capital
Pennsylvania
-$1.81M
4
Franklin Resources
Franklin Resources
California
-$1.58M
5
Morgan Stanley
Morgan Stanley
New York
-$1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Prudential Financial
51
Prudential Financial
New Jersey
$317K -$1.11K -200 -0.3%
BJ
52
BlackRock Japan
Japan
$310K +$265K +47,674 +356%
Millennium Management
53
Millennium Management
New York
$308K -$760K -136,522 -69%
I2I
54
Insight 2811 Inc
Illinois
$304K -$27.8K -5,000 -8%
CBOA
55
Commonwealth Bank of Australia
Australia
$294K +$301K +53,993 +1,370%
CCMH
56
Cornerstone Capital Management Holdings
New York
$292K -$201K -36,055 -39%
Invesco
57
Invesco
Georgia
$289K +$155K +27,831 +96%
RhumbLine Advisers
58
RhumbLine Advisers
Massachusetts
$285K -$2.73K -491 -0.9%
Susquehanna International Group
59
Susquehanna International Group
Pennsylvania
$279K +$307K +55,072 New
ProShare Advisors
60
ProShare Advisors
Maryland
$270K +$33.5K +6,008 +13%
NFA
61
Nationwide Fund Advisors
Ohio
$267K +$3.81K +685 +1%
Swiss National Bank
62
Swiss National Bank
Switzerland
$263K – – –
MLICM
63
Metropolitan Life Insurance Company (MetLife)
New York
$246K +$7.08K +1,272 +3%
PPA
64
Parametric Portfolio Associates
Washington
$225K +$40K +7,183 +19%
Fidelity International
65
Fidelity International
Bermuda
$206K +$226K +40,578 New
Los Angeles Capital Management
66
Los Angeles Capital Management
California
$196K +$215K +38,573 New
State Board of Administration of Florida Retirement System
67
State Board of Administration of Florida Retirement System
Florida
$187K – – –
VOYA Investment Management
68
VOYA Investment Management
Georgia
$187K – – –
AIG
69
American International Group
New York
$184K -$16K -2,869 -7%
SIM
70
Spark Investment Management
New York
$181K +$199K +35,800 New
Public Employees Retirement Association of Colorado
71
Public Employees Retirement Association of Colorado
Colorado
$180K – – –
BA
72
Boston Advisors
Massachusetts
$176K +$66.3K +11,900 +52%
DekaBank Deutsche Girozentrale
73
DekaBank Deutsche Girozentrale
Germany
$153K +$168K +30,100 New
Morgan Stanley
74
Morgan Stanley
New York
$142K -$1M -180,134 -87%
Tudor Investment Corp
75
Tudor Investment Corp
Connecticut
$142K +$12.8K +2,300 +9%
1 2
3
4 5

SCLN Hedge Fund Activity: Q3 2013 in Review

102 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Sciclone Pharmaceuticals Inc (SCLN) for Q3 2013, worth a combined $148M — up 0.67% from $147M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of SCLN and 14 opened new positions — a net loss of 2 holders — while 34 trimmed existing stakes and 41 added.

The largest buyer was Acadian Asset Management, adding an estimated $4.2M. The largest seller was Schroder Investment Management Group, cutting an estimated $11.4M.

  • 102 institutional investors held Sciclone Pharmaceuticals Inc (SCLN) as of Q3 2013, down from 104 in Q2 2013.
  • Funds reported $148M of Sciclone Pharmaceuticals Inc stock for Q3 2013, up 0.67% quarter-over-quarter.
  • 14 funds opened new Sciclone Pharmaceuticals Inc positions in Q3 2013 and 16 closed out, a net change of -2 holders.
  • The largest Sciclone Pharmaceuticals Inc buyer in Q3 2013 was Acadian Asset Management, an estimated $4.2M added.
  • The largest Sciclone Pharmaceuticals Inc seller in Q3 2013 was Schroder Investment Management Group, an estimated $11.4M sold.

Based on aggregated 13F filings for Q3 2013.